sBLA submission

Related by string. * : License Application sBLA . sBLA . sBLA filings / SUBMISSION . submissions . SUBMISSIONS . Submissions . Submission : Letters submission form . submission triangle choke . submission guillotine choke . BLA submission . MAA submission . NDA submission . Drug Submission NDS . spam submissions . Samoan Submission Machine . PMA submission . Submission deadline * *

Related by context. Frequent words. (Click for all words.) 61 Amrubicin 60 phase IIb clinical 60 NVA# 59 R sorafenib tablets 59 Phase 1b clinical 59 Nexavar ® 59 LIALDA 59 phase IIb 59 liposomal formulation 58 Targretin 58 Gemzar ® 58 Hycamtin 58 Taxotere ® 58 Panzem R 58 COPEGUS 58 HCV protease inhibitor 58 BLA submission 58 metastatic hormone refractory 58 pulmonology portfolio 58 elotuzumab 58 Cimzia R 58 Rebif ® 58 application sNDA 58 ANYARA 58 Pegasys ® 57 Lenalidomide 57 Torisel 57 Pegintron 57 indacaterol 57 Clevudine 57 FOLFIRI 57 Phase Ib clinical 57 pertuzumab 56 mTOR inhibitor 56 INTEGRILIN 56 Phase 1b trial 56 Pivotal Trial 56 relapsed refractory multiple myeloma 56 Dasatinib 56 aflibercept 56 goserelin 56 bevacizumab Avastin 56 QNEXA 56 plus gemcitabine 56 methylnaltrexone 56 SPD# 56 deforolimus 56 Avastin bevacizumab 56 TRISENOX 56 active comparator 56 Pivotal Phase III 56 PegIntron 56 Solzira 56 phase 2a 56 axitinib 56 Phase 1b 56 Phase 2b clinical 55 Paraplatin 55 peginterferon alfa 2b 55 ROTATEQ 55 Erlotinib 55 daptomycin 55 Avandaryl 55 Mipomersen 55 PEG SN# 55 phase IIa 55 multi kinase inhibitor 55 temsirolimus 55 Pirfenidone 55 muraglitazar 55 IIa trial 55 relapsing multiple sclerosis 55 anticancer compound 55 Neurodex 55 BEMA TM Fentanyl 55 placebo controlled Phase 55 Vilazodone 55 OPAXIO 55 Ampligen R 55 MNTX 55 Icatibant 55 Orphan Drug status 55 placebo controlled clinical 55 bazedoxifene 55 interferon alfa 55 SCHWARZ PHARMA 55 SinuNase 55 RITUXAN 55 angiogenesis inhibitor 55 confirmatory Phase III 55 pazopanib 55 Phase Ib 55 FIRAZYR 55 FDA approvable letter 55 dalbavancin 55 plus dexamethasone 55 ponatinib 55 Vandetanib 55 KNS # 55 dirucotide 55 Phase 2a clinical

Back to home page